Literature DB >> 12702554

Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene.

Charlotta Lindvall1, Mi Hou, Toshi Komurasaki, Chengyun Zheng, Marie Henriksson, John M Sedivy, Magnus Björkholm, Bin Tean Teh, Magnus Nordenskjöld, Dawei Xu.   

Abstract

Reconstitution of telomerase activity by ectopic expression of telomerase reverse transcriptase (hTERT) results in an immortal phenotype in various types of normal human cells, including fibroblasts. Despite lack of transformation characteristics, it is unclear whether hTERT-immortalized cells are physiologically and biochemically the same as their normal counterparts. Here, we compared the gene expression profiles of normal and hTERT-immortalized fibroblasts by using a cDNA microarray containing 20,736 cDNA clones and identified 172 dysregulated genes or expressed sequence tags (ESTs). One of the highly expressed genes in the hTERT-immortalized fibroblasts (hTERT-BJ cells) encodes epiregulin, a potent growth factor. Blockade of epiregulin reduced the growth of hTERT-BJ cells and colony formation of hTERT-transformed fibroblasts. Moreover, inhibition of epiregulin function in immortal hTERT-BJ cells triggered a senescence program. Our results suggest that both activation of telomerase and subsequent induction of epiregulin are required for sustained cell proliferation. Given the significant difference in gene expression profiles between normal and hTERT-immortalized fibroblasts and the close relationship between epiregulin and tumorigenesis, we conclude that hTERT-immortalized cells may not replace their normal counterparts for studies of normal cell biology and that the use of hTERT for expansion of normal human cells for therapeutic purposes must be approached with caution.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12702554

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Genomic sites hypersensitive to ultraviolet radiation.

Authors:  Sanjay Premi; Lynn Han; Sameet Mehta; James Knight; Dejian Zhao; Meg A Palmatier; Karl Kornacker; Douglas E Brash
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-13       Impact factor: 11.205

2.  Epiregulin can promote proliferation of stem cells from the dental apical papilla via MEK/Erk and JNK signalling pathways.

Authors:  Y Cao; D S Xia; S R Qi; J Du; P Ma; S L Wang; Z P Fan
Journal:  Cell Prolif       Date:  2013-07-06       Impact factor: 6.831

3.  [Enhanced control of proliferation in telomerized cells].

Authors:  E E Egorov; M V Moldaver; Kh S Vishniakova; S M Terekhov; E B Dashinimaev; I B Cheglakov; I Iu Toropygin; K N Iarygin; P M Chumakov; L I Korochkin; G A Antonova; E Iu Rybalkina; I N Saburina; N S Burnaevskiĭ; A V Zelenin
Journal:  Ontogenez       Date:  2007 Mar-Apr

4.  Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas.

Authors:  Shaowei Li; Fumiko Takeuchi; Ji-An Wang; Qingyuan Fan; Toshi Komurasaki; Eric M Billings; Gustavo Pacheco-Rodriguez; Joel Moss; Thomas N Darling
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

5.  Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.

Authors:  N Sunaga; K Kaira; H Imai; K Shimizu; T Nakano; D S Shames; L Girard; J Soh; M Sato; Y Iwasaki; T Ishizuka; A F Gazdar; J D Minna; M Mori
Journal:  Oncogene       Date:  2012-09-10       Impact factor: 9.867

6.  Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage.

Authors:  Daekee Lee; R Scott Pearsall; Sanjoy Das; Sudhansu K Dey; Virginia L Godfrey; David W Threadgill
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

7.  Quantitative proteomic analysis of human breast epithelial cells with differential telomere length.

Authors:  Li-Rong Yu; King C Chan; Hidetoshi Tahara; David A Lucas; Koushik Chatterjee; Haleem J Issaq; Timothy D Veenstra
Journal:  Biochem Biophys Res Commun       Date:  2007-03-22       Impact factor: 3.575

8.  Normal human fibroblasts are resistant to RAS-induced senescence.

Authors:  Jennifer A Benanti; Denise A Galloway
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.

Authors:  Jessica Kao; Keyan Salari; Melanie Bocanegra; Yoon-La Choi; Luc Girard; Jeet Gandhi; Kevin A Kwei; Tina Hernandez-Boussard; Pei Wang; Adi F Gazdar; John D Minna; Jonathan R Pollack
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

10.  Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.

Authors:  Astrid Rohrbeck; Jürgen Borlak
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.